VAERS reports by lot

Pfizer COVID-19 lot EWO171: VAERS reports

56 VAERS reports list lot EWO171 as a Pfizer COVID-19 vaccine, received between 2021-04-21 and 2024-12-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
56
Reports
4%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological5621%
General / Systemic (non-local)5119%
Musculoskeletal3513%
Cardiac / Cardiovascular2811%
Respiratory239%
Gastrointestinal228%
Allergic / Anaphylactic156%
Dermatological (non-injection-site)114%
Psychiatric / Neuropsychiatric93%
Injection-site / Local reaction93%
Autoimmune / Immune-mediated31%
Thrombotic / Hematological21%
Reproductive / Menstrual21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California12
Florida7
Rhode Island3
New Jersey3
Indiana3
Michigan2
Illinois2
Massachusetts2
Texas2
Virginia2
Oregon2
North Carolina2

Reports by month received

2021-049
2021-0515
2021-066
2021-073
2021-083
2021-095
2021-101
2021-111
2021-122
2022-011
2022-023
2022-032
2022-041
2022-051
2022-071
2022-121
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.